Open AccessComparative Effect of Tyrosine Kinase Inhibitors in Human Cancer Cell Lines
Author(s) -
Gandhali Deshpande
Publication year - 2016
Publication title -
journal of pharmacology and clinical research
Language(s) - English
Resource type - Journals
ISSN - 2473-5574
DOI - 10.19080/jpcr.2016.01.555557
Subject(s) - erlotinib , tyrosine kinase , sorafenib , dasatinib , cancer research , carcinoma cell , cancer , carcinoma , proto oncogene tyrosine protein kinase src , tyrosine kinase inhibitor , medicine , in vitro , platelet derived growth factor receptor , oncology , biology , hepatocellular carcinoma , receptor , biochemistry , epidermal growth factor receptor , growth factor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom